591 related articles for article (PubMed ID: 12791812)
21. Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.
Tissingh G; Bergmans P; Booij J; Winogrodzka A; van Royen EA; Stoof JC; Wolters EC
J Neurol; 1998 Jan; 245(1):14-20. PubMed ID: 9457623
[TBL] [Abstract][Full Text] [Related]
22. [123I]beta-CIT SPECT visualizes dopamine transporter loss in de novo parkinsonian patients.
Müller T; Farahati J; Kuhn W; Eising EG; Przuntek H; Reiners C; Coenen HH
Eur Neurol; 1998; 39(1):44-8. PubMed ID: 9476723
[TBL] [Abstract][Full Text] [Related]
23. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
[TBL] [Abstract][Full Text] [Related]
24. [123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients.
Haapaniemi TH; Ahonen A; Torniainen P; Sotaniemi KA; Myllylä VV
Mov Disord; 2001 Jan; 16(1):124-30. PubMed ID: 11215571
[TBL] [Abstract][Full Text] [Related]
25. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
Scanley BE; al-Tikriti MS; Gandelman MS; Laruelle M; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Hoffer PB; Charney DS; Wang S
Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
[TBL] [Abstract][Full Text] [Related]
26. In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.
Parsey RV; Kegeles LS; Hwang DR; Simpson N; Abi-Dargham A; Mawlawi O; Slifstein M; Van Heertum RL; Mann JJ; Laruelle M
J Nucl Med; 2000 Sep; 41(9):1465-77. PubMed ID: 10994724
[TBL] [Abstract][Full Text] [Related]
27. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
[TBL] [Abstract][Full Text] [Related]
28. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
29. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.
Booij J; Tissingh G; Winogrodzka A; Boer GJ; Stoof JC; Wolters EC; van Royen EA
Eur J Nucl Med; 1997 Jan; 24(1):68-71. PubMed ID: 9044880
[TBL] [Abstract][Full Text] [Related]
30. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
[TBL] [Abstract][Full Text] [Related]
31. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK
J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
[TBL] [Abstract][Full Text] [Related]
32. [Dopamine transporter SPECT in patients with Parkinson's disease].
Hamano T; Tsuchida T; Hirayama M; Fujiyama J; Mutoh T; Yonekura Y; Kuriyama M
Kaku Igaku; 2000 Mar; 37(2):125-9. PubMed ID: 10783572
[TBL] [Abstract][Full Text] [Related]
33. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
34. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
Bergström KA; Kuikka JT; Ahonen A; Vanninen E
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
[TBL] [Abstract][Full Text] [Related]
35. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
Booij J; Hemelaar TG; Speelman JD; de Bruin K; Janssen AG; van Royen EA
J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746
[TBL] [Abstract][Full Text] [Related]
36. Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease.
Prunier C; Payoux P; Guilloteau D; Chalon S; Giraudeau B; Majorel C; Tafani M; Bezard E; Esquerré JP; Baulieu JL
J Nucl Med; 2003 May; 44(5):663-70. PubMed ID: 12732666
[TBL] [Abstract][Full Text] [Related]
37. Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis.
Schwarz J; Linke R; Kerner M; Mozley PD; Trenkwalder C; Gasser T; Tatsch K
Arch Neurol; 2000 Feb; 57(2):205-8. PubMed ID: 10681078
[TBL] [Abstract][Full Text] [Related]
38. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.
Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914
[TBL] [Abstract][Full Text] [Related]
39. Imaging of serotonin and dopamine transporters in the living human brain.
Kuikka JT; Tiihonen J; Bergström KA; Karhu J; Hartikainen P; Viinamäki H; Länsimies E; Lehtonen J; Hakola P
Eur J Nucl Med; 1995 Apr; 22(4):346-50. PubMed ID: 7607266
[TBL] [Abstract][Full Text] [Related]
40. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
